Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1979 1
1980 1
1982 1
1983 1
1984 4
1985 11
1986 3
1987 16
1988 14
1989 27
1990 26
1991 21
1992 19
1993 19
1994 25
1995 27
1996 27
1997 33
1998 34
1999 30
2000 29
2001 31
2002 23
2003 41
2004 37
2005 37
2006 41
2007 31
2008 26
2009 33
2010 36
2011 32
2012 40
2013 40
2014 34
2015 26
2016 42
2017 54
2018 43
2019 40
2020 45
2021 50
2022 48
2023 30
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

1,141 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Lupus anticoagulant disorder"
Page 1
Antiphospholipid syndrome.
Sammaritano LR. Sammaritano LR. Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101463. doi: 10.1016/j.berh.2019.101463. Epub 2019 Dec 19. Best Pract Res Clin Rheumatol. 2020. PMID: 31866276 Review.
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial, venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or pregnancy morbidity in the setting of documented persistent antiphospholipid antibodies that inc …
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial, venous, or small vessel thrombosis and/or rec …
Laboratory Diagnostics in Thrombophilia.
Linnemann B, Hart C. Linnemann B, et al. Hamostaseologie. 2019 Feb;39(1):49-61. doi: 10.1055/s-0039-1677840. Epub 2019 Jan 31. Hamostaseologie. 2019. PMID: 30703819 Review.
A thrombophilic disorder is a hereditary or acquired condition that increases the risk of thrombosis. ...Immunologic antigen assays and chromogenic or clot-based activity assays are used to identify deficiencies in the natural coagulation inhibitors antithrombin, pr …
A thrombophilic disorder is a hereditary or acquired condition that increases the risk of thrombosis. ...Immunologic antigen assays a …
Antiphospholipid antibodies.
Levine SR, Welch KM. Levine SR, et al. Ann Neurol. 1989 Sep;26(3):386-9. doi: 10.1002/ana.410260312. Ann Neurol. 1989. PMID: 2508536 Review.
Lupus anticoagulants and anticardiolipin antibodies, known collectively as antiphospholipid antibodies, are becoming established as markers for increased risk of thrombosis, including ischemic cerebrovascular disease. In this brief review, we highlight evidence for …
Lupus anticoagulants and anticardiolipin antibodies, known collectively as antiphospholipid antibodies, are becoming established as m …
Management of maternal antiphospholipid syndrome.
Fernandes MA, Gerardi MC, Andreoli L, Tincani A. Fernandes MA, et al. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):149-156. Epub 2019 Jun 28. Clin Exp Rheumatol. 2020. PMID: 31287415 Review.
Antiphospholipid syndrome (APS) is a systemic autoimmune disease which manifests as thrombotic and/or obstetric adverse events, mediated by persistent circulating antiphospholipid antibodies (aPL) detected by means of three tests: lupus anticoagulant, anticar …
Antiphospholipid syndrome (APS) is a systemic autoimmune disease which manifests as thrombotic and/or obstetric adverse events, media …
Lupus anticoagulant.
Creagh MD, Greaves M. Creagh MD, et al. Blood Rev. 1991 Sep;5(3):162-7. doi: 10.1016/0268-960x(91)90033-9. Blood Rev. 1991. PMID: 1777749 Review.
Acquired antibodies to phospholipids form a heterogeneous group, which may be detected in vitro by the inhibition of phospholipid dependent tests of coagulation (lupus anticoagulant) and also by immunological assays, such that a combined approach is required …
Acquired antibodies to phospholipids form a heterogeneous group, which may be detected in vitro by the inhibition of phospholipid dependent …
Lupus anticoagulant and mortality in patients hospitalized for COVID-19.
Gazzaruso C, Mariani G, Ravetto C, Malinverni L, Tondelli E, Cerrone M, Sala V, Bevilacqua L, Altavilla T, Coppola A, Gallotti P. Gazzaruso C, et al. J Thromb Thrombolysis. 2021 Jul;52(1):85-91. doi: 10.1007/s11239-020-02335-w. Epub 2020 Nov 7. J Thromb Thrombolysis. 2021. PMID: 33159639 Free PMC article.
However, the association between lupus anticoagulant and thrombotic complications in COVID-19 is controversial and no study has specifically evaluated the impact of lupus anticoagulant on mortality. ...Lupus anticoagulant was found in 95 …
However, the association between lupus anticoagulant and thrombotic complications in COVID-19 is controversial and no study ha …
Lupus anticoagulants in children.
Briones M, Abshire T. Briones M, et al. Curr Opin Hematol. 2003 Sep;10(5):375-9. doi: 10.1097/00062752-200309000-00009. Curr Opin Hematol. 2003. PMID: 12913793 Review.
Lupus anticoagulant and ACAs are made up of heterogeneous IgG and IgM antibodies that prolong in vitro clotting times and are associated with increased risks of venous and arterial thrombosis, recurrent fetal loss, and autoimmune thrombocytopenia and anemia. ...Isol …
Lupus anticoagulant and ACAs are made up of heterogeneous IgG and IgM antibodies that prolong in vitro clotting times and are …
Diagnosis of antiphospholipid syndrome.
Bertolaccini ML, Khamashta MA. Bertolaccini ML, et al. Expert Rev Hematol. 2008 Dec;1(2):183-8. doi: 10.1586/17474086.1.2.183. Expert Rev Hematol. 2008. PMID: 21082923 Review.
Antiphospholipid syndrome is a multisystem autoimmune disease, characterized by recurrent vascular thrombosis and/or pregnancy losses in the presence of persistently positive antiphospholipid antibodies. In clinical practice, testing for anticardiolipin antibodies and l …
Antiphospholipid syndrome is a multisystem autoimmune disease, characterized by recurrent vascular thrombosis and/or pregnancy losses …
The antiphospholipid antibodies.
Tanaseanu C, Moldoveanu E, Tanaseanu S, Popescu LM. Tanaseanu C, et al. Haematologia (Budap). 2002;31(4):287-302. doi: 10.1163/15685590160141314. Haematologia (Budap). 2002. PMID: 12038512 Review.
This article presents the characteristics of some APLAs [anticardiolipin antibodies (aCLAs), lupus anticoagulant (LA) and anti-beta2-glycoprotein I antibodies (anti-beta2-GPIAs)], their action, and their interaction with blood and endothelial cells. The presence of …
This article presents the characteristics of some APLAs [anticardiolipin antibodies (aCLAs), lupus anticoagulant (LA) and anti …
Antiphospholid antibodies and the risk of pregnancy complications.
Gris JC, Bouvier S, Nouvellon E, Lissalde-Lavigne G, Mercier E, Balducchi JP, Marès P. Gris JC, et al. Thromb Res. 2017 Mar;151 Suppl 1:S34-S37. doi: 10.1016/S0049-3848(17)30064-6. Thromb Res. 2017. PMID: 28262231 Review.
Among these three obstetrical morbidities, only the first one is however not regularly questioned. The coexistence of an inflammatory disease and/or of thrombotic manifestations increases the obstetrical risks. Among the three criteria APLAbs, i.e. lupus anticoag …
Among these three obstetrical morbidities, only the first one is however not regularly questioned. The coexistence of an inflammatory dis …
1,141 results